UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunometabolism: From basic mechanisms to translation

Immunological reviews, 2020-05, Vol.295 (1), p.5-14

2020

Volltextzugriff (PDF)

Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer

Frontiers in cell and developmental biology, 2020-05, Vol.8, p.351

2020

Volltextzugriff (PDF)

TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma

Journal of gastrointestinal surgery, 2022, Vol.26 (1), p.113-121

2022

Volltextzugriff (PDF)

TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response

Cell reports (Cambridge), 2022-06, Vol.39 (11), p.110937-110937, Article 110937

2022

Volltextzugriff (PDF)

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

Cell reports (Cambridge), 2024-11, Vol.43 (11), p.114875, Article 114875

2024

Volltextzugriff (PDF)

Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore

Communications biology, 2022-11, Vol.5 (1), p.1181-15, Article 1181

2022

Volltextzugriff (PDF)

Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions

Pharmacology & therapeutics (Oxford), 2023-04, Vol.244, p.108370-108370, Article 108370

2023

Volltextzugriff (PDF)

Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity

Immunological reviews, 2020-05, Vol.295 (1), p.220-239

2020

Volltextzugriff (PDF)

Abstract LB-A33: Mitogen activated protein kinase (MAPK) signaling in neprilysin-hypermethylated breast cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.LB-A33-LB-A33

2018

Volltextzugriff (PDF)

Targeting Myeloid Protein Kinase C Signaling to Overcome Immune Suppression and Improve Immunotherapy in Cancer

Chaib, Mehdi

2022

Volltextzugriff (PDF)

Abstract 118: Myeloid PKCd activation inhibits innate immune suppression and promotes antigen cross-presentation in triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.118-118

2021

Volltextzugriff (PDF)

Fr642 TGF-β RECEPTOR INHIBITION ENHANCES DUAL-IMMUNE CHECKPOINT INHIBITION THERAPY IN PANCREATIC CANCER

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-915-S-915

2021

Volltextzugriff (PDF)

Abstract PS17-46: Pkc agonism restricts immune suppression and promotes antigen cross-presentation in triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS17-46-PS17-46

2021

Volltextzugriff (PDF)

Abstract 2647: MUC13 interacts with SOX2 leading to cell stemness and Anoikis resistance in colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2647-2647

2019

Volltextzugriff (PDF)

Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer

Cell reports (Cambridge), 2021-06, Vol.35 (12), p.109285-109285, Article 109285

2021

Volltextzugriff (PDF)

Abstract PS17-29: Surgically induced weight loss corrects obesity associated tumor progression and improves responsiveness to immunotherapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS17-29-PS17-29

2021

Volltextzugriff (PDF)

The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells

Molecular carcinogenesis, 2022-06, Vol.61 (6), p.549-557

2022

Volltextzugriff (PDF)

Abstract PS17-04: Immune checkpoint blockade reprograms tumor microenvironment and systemic immune landscape in obesity associated triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS17-04-PS17-04

2021

Volltextzugriff (PDF)

PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer

Cancer letters, 2022-04, Vol.531, p.98-108

2022

Volltextzugriff (PDF)

Abstract 5777: Ormeloxifene augments the therapeutic response of enzalutamide via targeting androgen receptor splice variant 7

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5777-5777

2018

Volltextzugriff (PDF)

Abstract LB-011: Novel nano-formulation of paclitaxel for pancreatic cancer therapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-011-LB-011

2018

Volltextzugriff (PDF)

Abstract 102: Ferrichrome suppresses pancreatic tumor growth via targeting TAMs and enhancing CD8+ T-cells infiltration

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.102-102

2019

Volltextzugriff (PDF)

Abstract 4427: Cucurbitacin B: A promising drug candidate for targeting tumor immunosuppressive cells

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4427-4427

2023

Volltextzugriff (PDF)

Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer

Science advances, 2023-12, Vol.9 (51), p.eadd3231-eadd3231

2023

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(41)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(10)
Immunotherapy
(8)
Animals
(7)
Humans
(7)
Mice
(7)
Tumor Microenvironment
(6)
Technology
(5)
Lymphocytes T
(4)
Phenotypes
(4)
Tumors
(4)
Automation & Control Systems
(3)
Cd8 Antigen
(3)
Cell Biology
(3)
Computer Science
(3)
Computer Science, Artificial Intelligence
(3)
Energy & Fuels
(3)
Immunity
(3)
Immunology
(3)
Macrophages
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunometabolism: From basic mechanisms to translation

Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer

TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma

TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery

Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore

Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions

Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity

Abstract LB-A33: Mitogen activated protein kinase (MAPK) signaling in neprilysin-hypermethylated breast cancer

Targeting Myeloid Protein Kinase C Signaling to Overcome Immune Suppression and Improve Immunotherapy in Cancer

Abstract 118: Myeloid PKCd activation inhibits innate immune suppression and promotes antigen cross-presentation in triple negative breast cancer

Fr642 TGF-β RECEPTOR INHIBITION ENHANCES DUAL-IMMUNE CHECKPOINT INHIBITION THERAPY IN PANCREATIC CANCER

Abstract PS17-46: Pkc agonism restricts immune suppression and promotes antigen cross-presentation in triple negative breast cancer

Abstract 2647: MUC13 interacts with SOX2 leading to cell stemness and Anoikis resistance in colorectal cancer

Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer

Abstract PS17-29: Surgically induced weight loss corrects obesity associated tumor progression and improves responsiveness to immunotherapy

The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells

Abstract PS17-04: Immune checkpoint blockade reprograms tumor microenvironment and systemic immune landscape in obesity associated triple negative breast cancer

PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer

Abstract 5777: Ormeloxifene augments the therapeutic response of enzalutamide via targeting androgen receptor splice variant 7

Abstract LB-011: Novel nano-formulation of paclitaxel for pancreatic cancer therapy

Abstract 102: Ferrichrome suppresses pancreatic tumor growth via targeting TAMs and enhancing CD8+ T-cells infiltration

Abstract 4427: Cucurbitacin B: A promising drug candidate for targeting tumor immunosuppressive cells

Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer

Suchergebnisse filtern